Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-30

Clinical Trial Update: To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether itraconazole and fluconazole alter the pharmacokinetics of selumetinib in healthy male volunteers. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)
  • Itraconazole (Itraconazole)
  • Selumetinib (selumetinib)

Snippet

Sponsor: AstraZeneca | Conditions: Solid Tumours | Phase 1 | Status: COMPLETED